SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-071593
Filing Date
2021-03-05
Accepted
2021-03-05 16:53:02
Documents
18
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A d42343dpre14a.htm PRE 14A 1560292
2 GRAPHIC g42343g0302211217949.jpg GRAPHIC 2105
3 GRAPHIC g42343g07b40.jpg GRAPHIC 68032
4 GRAPHIC g42343g10m66.jpg GRAPHIC 183373
5 GRAPHIC g42343g13b23.jpg GRAPHIC 11267
6 GRAPHIC g42343g31z98.jpg GRAPHIC 65984
7 GRAPHIC g42343g34e30.jpg GRAPHIC 175811
8 GRAPHIC g42343g45m91.jpg GRAPHIC 20839
9 GRAPHIC g42343g48l10.jpg GRAPHIC 143960
10 GRAPHIC g42343g52q90.jpg GRAPHIC 18604
11 GRAPHIC g42343g52x44.jpg GRAPHIC 141773
12 GRAPHIC g42343g54y89.jpg GRAPHIC 18056
13 GRAPHIC g42343g57b62.jpg GRAPHIC 20754
14 GRAPHIC g42343g62s54.jpg GRAPHIC 51518
15 GRAPHIC g42343g75g63.jpg GRAPHIC 36177
16 GRAPHIC g42343g85s48.jpg GRAPHIC 98911
17 GRAPHIC g42343g85v04.jpg GRAPHIC 167049
18 GRAPHIC g42343g99m92.jpg GRAPHIC 182745
  Complete submission text file 0001193125-21-071593.txt   3487014
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35238 | Film No.: 21719201
SIC: 2834 Pharmaceutical Preparations